Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Jul 1, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 285.89 - 304.01
Feb 7, 2014 sanofi Beneficial Owner (10% or more) Buy 21,986 284.49 - 289.98
Feb 6, 2014 sanofi Beneficial Owner (10% or more) Buy 146,525 282.84 - 287.88
Feb 4, 2014 sanofi Beneficial Owner (10% or more) Buy 190,286 282.05 - 287.78
Feb 3, 2014 sanofi Beneficial Owner (10% or more) Buy 198,058 279.14 - 289.62
May 14, 2013 aberman michael s Officer Automatic Sell 5,529 278.72 - 281.72
May 15, 2013 brown michael s Director Sell 10,000 278.28
May 13, 2013 stahl neil Officer Sell 23,038 276.71 - 277.12
Dec 31, 2013 powchik peter Officer Automatic Sell 27,332 276.09
May 13, 2013 aberman michael s Officer Automatic Sell 6,971 275.97
Jun 30, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 275.68 - 284.53
Sep 9, 2013 schleifer leonard s Officer Automatic Sell 5,000 275.04 - 277.12
Feb 5, 2014 sanofi Beneficial Owner (10% or more) Buy 206,978 274.64 - 288.13
Jan 28, 2014 sanofi Beneficial Owner (10% or more) Buy 83,235 273.44 - 279.26
Dec 12, 2013 yancopoulos george Officer Automatic Sell 9,382 273.06
Jan 2, 2014 powchik peter Officer Automatic Sell 20,668 272.88 - 277.50
Dec 16, 2013 goldberg murray a Officer Automatic Sell 5,157 272.73
Dec 16, 2013 powchik peter Officer Automatic Sell 21,617 272.73
Dec 16, 2013 stahl neil Officer Automatic Sell 9,302 272.73
Dec 16, 2013 yancopoulos george Officer Automatic Sell 42,974 272.73
Showing 121-140 of 887 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)